Study of Tetrathiomolybdate in Patients With Wilson Disease

Completed · Phase 3

Conditions studied: Wilson Disease

In brief

OBJECTIVES: Evaluate the safety and efficacy of ammonium tetrathiomolybdate alone and compared with trientine therapy as initial treatment in patients with Wilson disease presenting neurologically.

Key facts

Study ID

NCT00004339

Run by

National Center for Research Resources (NCRR)

People needed

90

Starts

1994-01-01

Last updated by the study team

2006-05-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.